These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 35657058)
1. Acute Unilateral Central Serous Chorioretinopathy after Immunization with Pfizer-BioNTech COVID-19 Vaccine: A Case Report and Literature Review. Rama Raj P; Adler PA; Chalasani R; Wan SL Semin Ophthalmol; 2022 Aug; 37(6):690-698. PubMed ID: 35657058 [TBL] [Abstract][Full Text] [Related]
2. Bilateral multifocal central serous retinopathy following mRNA COVID-19 vaccine. Mechleb N; Khoueir Z; Assi A J Fr Ophtalmol; 2022 Jun; 45(6):603-607. PubMed ID: 35599048 [TBL] [Abstract][Full Text] [Related]
3. Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine. Fowler N; Mendez Martinez NR; Pallares BV; Maldonado RS Am J Ophthalmol Case Rep; 2021 Sep; 23():101136. PubMed ID: 34151047 [TBL] [Abstract][Full Text] [Related]
4. Unilateral recurrent central serous chorioretinopathy (CSCR) following COVID-19 vaccination- A multimodal imaging study. Sanjay S; Acharya I; Kawali A; Shetty R; Mahendradas P Am J Ophthalmol Case Rep; 2022 Sep; 27():101644. PubMed ID: 35818570 [TBL] [Abstract][Full Text] [Related]
5. Central serous chorioretinopathy following Pfizer-BioNTech COVID-19 vaccine: A case report. Delbarre M; Maréchal M; Froussart-Maille F J Fr Ophtalmol; 2022 Jan; 45(1):e1-e2. PubMed ID: 34949501 [No Abstract] [Full Text] [Related]
6. Central serous chorioretinopathy in patients receiving exogenous testosterone therapy. Nudleman E; Witmer MT; Kiss S; Williams GA; Wolfe JD Retina; 2014 Oct; 34(10):2128-32. PubMed ID: 24946102 [TBL] [Abstract][Full Text] [Related]
7. Clinical parameters related to metamorphopsia outcome in patients with resolved central serous chorioretinopathy using M-CHARTS: retrospective cohort study. Bae S; Jin K; Kim H; Bae SH BMC Ophthalmol; 2015 Dec; 15():180. PubMed ID: 26677843 [TBL] [Abstract][Full Text] [Related]
8. Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022. Hause AM; Baggs J; Marquez P; Abara WE; Olubajo B; Myers TR; Su JR; Thompson D; Gee J; Shimabukuro TT; Shay DK MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(9):347-351. PubMed ID: 35239637 [TBL] [Abstract][Full Text] [Related]
10. Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5-11 Years - United States, May 17-July 31, 2022. Hause AM; Baggs J; Marquez P; Myers TR; Su JR; Hugueley B; Thompson D; Gee J; Shimabukuro TT; Shay DK MMWR Morb Mortal Wkly Rep; 2022 Aug; 71(33):1047-1051. PubMed ID: 35980875 [TBL] [Abstract][Full Text] [Related]
11. Central serous chorioretinopathy following the BNT162b2 mRNA vaccine. Hanhart J; Roditi E; Wasser LM; Barhoum W; Zadok D; Brosh K J Fr Ophtalmol; 2022 Jun; 45(6):597-602. PubMed ID: 35577701 [TBL] [Abstract][Full Text] [Related]
12. Exacerbation of immune thrombocytopenia following initial and booster vaccination with Pfizer-BioNTech COVID-19 vaccine. Aharoni M; Leader A; Shochat T; Raanani P; Spectre G Platelets; 2022 Jul; 33(5):781-786. PubMed ID: 35536172 [TBL] [Abstract][Full Text] [Related]
13. Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans - Five Veterans Affairs Medical Centers, United States, February 1-September 30, 2021. Bajema KL; Dahl RM; Evener SL; Prill MM; Rodriguez-Barradas MC; Marconi VC; Beenhouwer DO; Holodniy M; Lucero-Obusan C; Brown ST; Tremarelli M; Epperson M; Mills L; Park SH; Rivera-Dominguez G; Morones RG; Ahmadi-Izadi G; Deovic R; Mendoza C; Jeong C; Schrag SJ; Meites E; Hall AJ; Kobayashi M; McMorrow M; Verani JR; Thornburg NJ; Surie D; ; ; MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(49):1700-1705. PubMed ID: 34882654 [TBL] [Abstract][Full Text] [Related]
14. A Case of Transient Visual Field Defect following Administration of Pfizer-BioNTech COVID-19 Vaccine. Sarıgül Sezenöz A; Güngör SG; Kibaroğlu S Ocul Immunol Inflamm; 2022 Jul; 30(5):1255-1259. PubMed ID: 35404749 [TBL] [Abstract][Full Text] [Related]
15. A Case of Neuroretinitis Following COVID-19 Vaccination. Yoshida N; Tsukada A Ocul Immunol Inflamm; 2023 Aug; 31(6):1261-1264. PubMed ID: 36306430 [TBL] [Abstract][Full Text] [Related]
16. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021. Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735 [TBL] [Abstract][Full Text] [Related]
17. Acute bilateral central serous chorioretinopathy in a young male after the first dose of Oxford/AstraZeneca AZD1222 (Covishield) vaccine. Sindhu M; Bamotra RK; Singh S Indian J Ophthalmol; 2023 Feb; 71(2):666-668. PubMed ID: 36727385 [TBL] [Abstract][Full Text] [Related]
18. mRNA COVID-19 Vaccine-Associated Subserosal Eosinophilic Gastroenteritis: A Case Report. Lee JY; Lee JH J Korean Med Sci; 2022 Aug; 37(30):e233. PubMed ID: 35916045 [TBL] [Abstract][Full Text] [Related]
19. Unilateral Acute Central Serous Chorioretinopathy with Inactivated Coronavirus Disease 2019 Vaccination: A Case Report and Review of Literature. Abrishami M; Hosseini SM; Shoeibi N; Heidarzadeh HR J Curr Ophthalmol; 2022; 34(3):373-378. PubMed ID: 36644462 [TBL] [Abstract][Full Text] [Related]
20. CENTRAL SEROUS CHORIORETINOPATHY ASSOCIATED WITH STEROID ENEMA. Peiris TJ; El Rami HE; Sun JK Retin Cases Brief Rep; 2021 Jan; 15(1):15-17. PubMed ID: 30063579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]